| Line Item | 2026-02-28 | Q/Q | Y/Y |
|---|---|---|---|
| R&D Expense | $22K | +124.4% | -43.5% |
| SG&A Expense | $14K | +16.7% | -33.4% |
| Operating Income | -$87K | -22.5% | +25.6% |
| Net Income | $389K | +620.3% | +436.7% |
| EPS (Basic) | $0.04 | +500.0% | +500.0% |
| EPS (Diluted) | $0.03 | +400.0% | +400.0% |
| Line Item | 2026-02-28 | Q/Q | Y/Y |
|---|---|---|---|
| Accounts Receivable | $8K | +54.1% | -5.9% |
| Current Assets | $421K | +649.2% | +320.6% |
| Total Assets | $421K | +531.3% | +280.7% |
| Current Liabilities | $299K | -12.3% | +5.9% |
| Stockholders' Equity | $123K | +145.1% | +172.1% |
| Line Item | 2026-02-28 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$206K | -264.7% | — |
| Investing Cash Flow | $506K | — | — |